| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | TRUFILL(R) N-BUTYL CYANOACRYLATE (N-BCA) LIQUID EMBOLIC SYSTEM |
| Generic Name | tissue adhesive for use in embolization of brain arteriovenous malformations |
| Applicant | Cerenovus, Inc. 6303 Waterford District Dr. Suite 315 Miami, FL 33126 |
| PMA Number | P990040 |
| Supplement Number | S001 |
| Date Received | 03/01/2001 |
| Decision Date | 05/30/2001 |
| Product Code |
KGG |
| Advisory Committee |
Neurology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Other |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement APPROVAL FOR REMOVAL OF THE POST ETHYLENE OXIDE STERILIZATION PYROGEN TEST OF THE N-BCA, REMOVAL OF THE POST-STERILIZATION FUNCTIONAL TESTING OF THE TANTALUM POWDER, THE ADDITION OF A PYROGEN TEST OF THE TANTALUM POWDER, AND THE VALIDATION OF THE PYROGENICITY TEST. |
|
|